| P2093 | author name string | Philippe Delerive | |
| | Florence Namour | |
| | Liên Lepescheux | |
| | Marielle Auberval | |
| | Philippe Clément-Lacroix | |
| | Roland Blanqué | |
| | Dominique Minet | |
| | Céline Cottereaux | |
| | Didier Merciris | |
| P2860 | cites work | Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy | Q24555065 |
| | The safety, pharmacokinetics, and effects of LGD-4033, a novel nonsteroidal oral, selective androgen receptor modulator, in healthy young men | Q24561868 |
| | In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker | Q24633015 |
| | Selective androgen receptor modulators in preclinical and clinical development | Q24645579 |
| | Myosin accumulation and striated muscle myopathy result from the loss of muscle RING finger 1 and 3 | Q24673171 |
| | Discovery of diarylhydantoins as new selective androgen receptor modulators | Q27681990 |
| | The steroid and thyroid hormone receptor superfamily | Q27861095 |
| | Nerve activity-independent regulation of skeletal muscle atrophy: role of MyoD and myogenin in satellite cells and myonuclei | Q28576625 |
| | Identification of ubiquitin ligases required for skeletal muscle atrophy | Q28582211 |
| | Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres | Q29555845 |
| | Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy | Q29619282 |
| | A PGC-1α isoform induced by resistance training regulates skeletal muscle hypertrophy | Q30415879 |
| | Limb immobilization induces a coordinate down-regulation of mitochondrial and other metabolic pathways in men and women | Q33490611 |
| | The role of cytokines in cancer cachexia | Q33610662 |
| | Medium chain acylcarnitines dominate the metabolite pattern in humans under moderate intensity exercise and support lipid oxidation | Q33633988 |
| | The proteasome inhibitor MG132 reduces immobilization-induced skeletal muscle atrophy in mice | Q33993411 |
| | The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial. | Q34029187 |
| | The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. | Q34062583 |
| | Myocytic androgen receptor controls the strength but not the mass of limb muscles | Q34069603 |
| | Skeletal muscle loss: cachexia, sarcopenia, and inactivity | Q34099406 |
| | Androgens and skeletal muscle: cellular and molecular action mechanisms underlying the anabolic actions. | Q34234465 |
| | Metabolic signatures of exercise in human plasma | Q34441396 |
| | Hindlimb unloading rodent model: technical aspects | Q34564818 |
| | PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription | Q34575428 |
| | Signaling in muscle atrophy and hypertrophy | Q34593198 |
| | Alterations of protein turnover underlying disuse atrophy in human skeletal muscle. | Q34609987 |
| | Sarcopenia and aging | Q35160882 |
| | Molecular mechanisms involved in muscle wasting in cancer and ageing: cachexia versus sarcopenia | Q36060206 |
| | Drug insight: Testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging | Q36130944 |
| | Modulations of muscle protein metabolism by branched-chain amino acids in normal and muscle-atrophying rats | Q36347115 |
| | Gene expression-based screening identifies microtubule inhibitors as inducers of PGC-1alpha and oxidative phosphorylation | Q36534424 |
| | The denervated muscle: facts and hypotheses. A historical review | Q36560326 |
| | Disruption of either the Nfkb1 or the Bcl3 gene inhibits skeletal muscle atrophy | Q37600956 |
| | Activation of an alternative NF-kappaB pathway in skeletal muscle during disuse atrophy | Q38290776 |
| | Identification of liver receptor homolog-1 as a novel regulator of apolipoprotein AI gene transcription | Q38339643 |
| | Glutamine prevents myostatin hyperexpression and protein hypercatabolism induced in C2C12 myotubes by tumor necrosis factor-α. | Q39681574 |
| | Steroidal androgens and nonsteroidal, tissue-selective androgen receptor modulator, S-22, regulate androgen receptor function through distinct genomic and nongenomic signaling pathways. | Q39938385 |
| | Testosterone protects against dexamethasone-induced muscle atrophy, protein degradation and MAFbx upregulation | Q39988401 |
| | The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle | Q40056196 |
| | Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex | Q40177208 |
| | A model of muscle atrophy using cast immobilization in mice | Q40404505 |
| | Degradation of MyoD mediated by the SCF (MAFbx) ubiquitin ligase | Q40494610 |
| | IKKbeta/NF-kappaB activation causes severe muscle wasting in mice | Q40505119 |
| | Leucine limitation induces autophagy and activation of lysosome-dependent proteolysis in C2C12 myotubes through a mammalian target of rapamycin-independent signaling pathway | Q40868615 |
| | Differential gene expression of muscle-specific ubiquitin ligase MAFbx/Atrogin-1 and MuRF1 in response to immobilization-induced atrophy of slow-twitch and fast-twitch muscles | Q42494029 |
| | Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases | Q42504415 |
| | Effects of a novel selective androgen receptor modulator on dexamethasone-induced and hypogonadism-induced muscle atrophy. | Q43037217 |
| | Little change in markers of protein breakdown and oxidative stress in humans in immobilization-induced skeletal muscle atrophy | Q43103586 |
| | Comparison of the anticatabolic effects of leucine and Ca-β-hydroxy-β-methylbutyrate in experimental models of cancer cachexia | Q43698451 |
| | Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy | Q44030256 |
| | Testosterone dose-dependently increases maximal voluntary strength and leg power, but does not affect fatigability or specific tension | Q44392830 |
| | Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control | Q44991663 |
| | Oxandrolone enhances hepatic ketogenesis in adult men. | Q46363283 |
| | Interleukin 1 and tumor necrosis factor do not regulate protein balance in skeletal muscle. | Q51627686 |
| | Impaired skeletal muscle development and function in male, but not female, genomic androgen receptor knockout mice. | Q51707697 |
| | A novel hindlimb immobilization procedure for studying skeletal muscle atrophy and recovery in mouse. | Q51738532 |
| | Early change in skeletal muscle protein synthesis after limb immobilization of rats | Q52770657 |
| | Branched-chain amino acids inhibit proteolysis in rat skeletal muscle: mechanisms involved. | Q54377633 |
| | FOXO1 regulates the expression of 4E-BP1 and inhibits mTOR signaling in mammalian skeletal muscle | Q56743003 |
| | Analysis of human skeletal muscle after 48 h immobilization reveals alterations in mRNA and protein for extracellular matrix components | Q60449676 |
| | Changes in signalling molecule levels in 10-day hindlimb immobilized rat muscles | Q81329948 |
| | Ornithine decarboxylase is upregulated by the androgen receptor in skeletal muscle and regulates myoblast proliferation | Q83905716 |
| | Identification of a 4-(hydroxymethyl)diarylhydantoin as a selective androgen receptor modulator | Q84946551 |
| | Branched-chain amino acids reduce hindlimb suspension-induced muscle atrophy and protein levels of atrogin-1 and MuRF1 in rats | Q85238238 |
| P304 | page(s) | 291 | |
| P577 | publication date | 2014-09-03 | |
| P1433 | published in | BMC Musculoskeletal Disorders | Q15751716 |
| P1476 | title | Characterization of GLPG0492, a selective androgen receptor modulator, in a mouse model of hindlimb immobilization | |
| P478 | volume | 15 | |